Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 2,611 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Sedentary Lifestyle, Knee Osteoarthritis, Knee Injuries, Knee Pain Chronic
Interventions: NEAT!2, NEAT!2+Calls, Delayed NEAT!2; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 40 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Obesity, Overweight, Anxiety, Mental Disorders, Body Weight, Eating Behavior, Feeding and Eating Disorders
Interventions: Interpersonal Psychotherapy (IPT), Cognitive Behavioral Theory (CBT); Behavioral
Lead sponsor: The Metis Foundation; Other
Eligibility: 12 Years to 17 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Fort Collins, Colorado • Bethesda, Maryland

Conditions: Inactivity, Sedentary Behavior
Interventions: Control condition, Treatment condition; Behavioral
Lead sponsor: Brandeis University; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Food Choices
Interventions: Control (QR Code) Menu Labels, Traffic-Light Style Environmental Harm Menu Labels; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years to 64 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Actinic Keratosis
Interventions: Ingenol mebutate; Drug
Lead sponsor: LEO Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Senile Purpura
Interventions: adapalene gel 0.3%; Drug
Lead sponsor: Multispecialty Aesthetic Clinical Research Organization; Other
Eligibility: 52 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Woodland Hills, California

Conditions: Plantar Fasciosis, Achilles Tendinosis
Interventions: TOPAZ MicroDebrider; Device
Lead sponsor: ArthroCare Corporation; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 3
States / cities: Mesa, Arizona • Santa Monica, California • Oakwood, Georgia

Conditions: Cavities of Teeth
Interventions: OpalSeal, TransbondXT; Device
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 10 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Chronic Pain
Interventions: Sham Phoenix Laser Treatment, Active Phoenix Laser Treatment; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Amputation, Upper Limb
Interventions: RESCU, Pattern Recognition; Device
Lead sponsor: Infinite Biomedical Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Silver Spring, Maryland

Conditions: Ocular GVHD
Interventions: Tacrolimus, Methylprednisolone Sodium Succinate; Drug
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Femur Fracture
Interventions: Femoral Traction; Procedure
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atopic Dermatitis
Interventions: Standard-of-care treatment for AD, Accu-patch pellet; Other · Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Systolic Heart Failure
Interventions: neuromodulation device, SHAM; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 85 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Knee Osteoarthritis, Hip Osteoarthritis
Interventions: Kaia hip and knee pain application, Treatment as usual; Behavioral · Other
Lead sponsor: Kaia Health Software; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Stamford, Connecticut

Conditions: Chemotherapy Induced Peripheral Neuropathy
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS); Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 80 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Gastroparesis
Interventions: Granisetron; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Airway Obstruction
Interventions: Jaw Elevation Device (JED); Device
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 48 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: San Diego, California

Conditions: Asthma
Interventions: ASTHMAXcel Voice platform; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Sunscreening Agents
Interventions: BAY987517, BullFrog Gel Sunscreen Land Sport SPF-50; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Brain Tumor, Pediatric Brain Tumor, Pediatric Cancer
Interventions: Diffusion tensor imaging (DTI), Resting state functional connectivity MRI (rs-fcMRI), Wechsler Intelligence Scale for Children - 5th edition (WISC-V), California Verbal Learning Test (CVLT-C), Beery Test of Visual Motor Integration 6th edition, Grooved Pegboard, PedsQL Multidimensional Fatigue Scale, MRI; Diagnostic Test · Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 6 Years to 16 Years
Enrollment: 42 participants
Timeline: 2017 – 2027
U.S. locations: 4
States / cities: New York, New York • Dallas, Texas • Seattle, Washington

Conditions: Actinic Keratosis
Interventions: Photodynamic therapy, Imiquimod; Drug
Lead sponsor: Tennessee Clinical Research Center; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 3
States / cities: Englewood, Colorado • Charlotte, North Carolina • Nashville, Tennessee

Conditions: Acne
Interventions: Doxycycline Anhydrous 40 MG, Adapalene/Benzoyl Peroxide Gel 0.3-2.5%; Drug
Lead sponsor: Derm Research, PLLC; Other
Eligibility: 12 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Photoallergy
Interventions: Induction: Application of MC2-01 Cream, irradiation, Induction: Application of MC2-01 Cream, no irradiation, Induction: Applications of MC2-01 vehicle, irradiation, Induction: Applications of MC2-01 vehicle, no irradiation, Challenge: Application of MC2-01 Cream, irradiation, Challenge: Application of MC2-01 Cream, no irradiation, Challenge: Applications of MC2-01 vehicle, irradiation, Challenge: Applications of MC2-01 vehicle, no irradiation, Challenge: Control, irradiation; Drug
Lead sponsor: MC2 Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Search by objective public record fields.

NEAT!2 Sedentary Behavior Reduction for Individuals With Past or Present Knee Symptoms, Injuries, or Surgeries

Addressing Anxiety and Stress for Healthier Eating in Teens

A Group-Based Walking Study Using WeChat to Enhance Physical Activity Among Older Adults

Environmental Harm Menu Labels and Overall Dietary Quality

Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions

A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura

Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis

An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients

Low-level Laser Therapy in Patients With Chronic Fibromyalgia

RESCU System for Robust Upper Limb Prosthesis Control

Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease

Skeletal Versus Cutaneous Traction For Treatment of Femur Fractures

Acupressure in Pruritus for Atopic Dermatitis

Neuromodulation of Inflammation and Endothelial Function

The Kaia Hip and Knee Pain Intervention for Self-management of the Pain in Patients With Osteoarthritis.

Self-applied taVNS for CIPN

Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis

Jaw Elevation Device in Deep Sedation Study

ASTHMAXcel Voice Study

Evaluation of a Gel Sunscreen in Controlled Use Conditions (208/2016)

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

The Use of Oracea and Epiduo Forte in Severe Acne Patients

Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream